Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
About Us
Media Contact
Frequently Asked Questions
Media Site Map

CDC News
Press Release Library
Transcripts
MMWR Summaries
B-Roll Footage
Upcoming Events

Related Links
Centers at CDC
Data and Statistics
Health Topics A-Z
Image Library
Publications, Software and Other Products
Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


MMWR
Synopsis for November 8, 2002

The MMWR is embargoed until 12 Noon ET, Thursdays.

  1. Adverse Events Associated With 17D-Derived Yellow Fever Vaccination -- United States, 2001-2002
  2. Vaginal Birth After Cesarean Birth -- California 1996-2000
  3. Global Progress Toward Laboratory Containment of Wild Polioviruses -- July 2001-August 2002
  4. West Nile Virus Activity -- United States, October 31-November 6, 2002

MMWR Reports and Recommendations
November 8, 2002/Vol 51/ No. 17

Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002
This report updates CDC's recommendations for the use of yellow fever vaccine.

Contact: Martin Cetron, MD
CDC, National Center for Infectious Diseases
(404) 498-1600

No telebriefing is scheduled for November 7, 2002

Synopsis for November 8, 2002

Adverse Events Associated With 17D-Derived Yellow Fever Vaccination -- United States, 2001-2002

Yellow fever vaccination is still recommended for persons aged >9 months traveling to countries where yellow fever is endemic or epidemic.

PRESS CONTACT:
Martin Cetron, MD

CDC, National Center for Infectious Diseases
(404) 4981600
 
Between May 2001- October 2002, CDC received reports of six cases of serious neurologic (4) and systemic (2) adverse events associated with yellow fever vaccination. These events are rare. Clinicians are encouraged to report to the Vaccine Adverse Event Reporting System patients with fever (>24 hours) or systemic illness within 30 days following vaccination. Despite these rare case reports, yellow fever is an important vaccine-preventable disease among travelers to, and those living in, the tropics of Africa and South America. Because of potential for high risk exposure to and severity of yellow fever infection, and the availability of an efficacious vaccine, ACIP and CDC continue to recommend yellow fever vaccination for persons aged >9 months traveling to countries where yellow fever is endemic or epidemic.

 

Vaginal Birth After Cesarean Birth -- California 1996-2000

PRESS CONTACT:
Sharon Durousseau

CDC, Epidemiology Program Office
(510) 7844794 (California)
 
Summary Not Available.

 

 

 

 

Global Progress Toward Laboratory Containment of Wild Polioviruses -- July 2001-August 2002

There has been substantial progress in identifying laboratories with wild poliovirus materials and in conducting national wild poliovirus inventories.

PRESS CONTACT:
Division of Media Relations

CDC, Office of Communication
(404) 639-3286
 
Since the World Health Assembly resolved in 1988 to eradicate poliomyelitis, the number of countries in which wild poliovirus is endemic has decreased from 125 to 10 in 2001. The Global Commission for the Certification of the Eradication of Poliomyelitis will declare the world polio-free when all regions have documented the absence of wild poliovirus transmission for at least 3 consecutive years and when laboratories with wild poliovirus materials have implemented appropriate containment conditions. This report describes preparations for laboratory containment, creation of a global inventory of laboratories and institutions retaining wild poliovirus, and summarizes global progress since July 2001. The data indicate that there has been substantial progress in identifying laboratories with wild poliovirus materials and in conducting national wild poliovirus inventories.

 

West Nile Virus Activity -- United States, October 31-November 6, 2002

PRESS CONTACT:
Division of Media Relations

CDC, Office of Communication
(404) 639-3286
 
Summary Not Available.

 

 

 

 


Media Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed November 8, 2002
URL:

Centers for Disease Control and Prevention
Office of Communication